AUSTIN, TX / ACCESS Newswire / January 29, 2026 / BetterWay(TM) blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, announced ...
At-home health testing platform Ash is expanding its partnership with weight-loss company Noom to bring Noom's Proactive Health Microdose GLP-1Rx Program to market. Noom's program, launched in August, ...
GLP-1 medications have changed the conversation around weight management and metabolic health. When prescribed appropriately, ...
Phenomix's MyPhenome test continues to demonstrate predictive accuracy in identifying which patients are most likely to respond to GLP-1 therapies such as semaglutide. Studies presented at Obesity ...
Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans ...
While McDonald's says it's "pretty protein-forward," the fast food chain is still looking to adapt its menu for GLP-1 users.
McDonald's is exploring ways to cater to the growing number of Americans taking GLP-1 weight-loss drugs, such as Ozempic and Wegovy, by testing high-protein menu items. CEO Chris Kempczinski revealed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results